Souhaitez-vous accéder aux communiqués récents ?

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Care Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.The Needle Free Diabetes Care Market...

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit solely focused on accelerating a cure for type 1 diabetes, announced the release of the 14th...

SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027 $10 million milestone payment triggered from licensing agreement with Novo Nordisk for LX9851 Zynquista on...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Europe Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "North America Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "European Association for the Study of Diabetes (EASD): Annual Meeting 2025 Highlights" report has been added to ResearchAndMarkets.com's offering.The...

Dublin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The "Self-Monitoring Blood Glucose (Smbg) Devices Market Outlook 2025-2034: Market Share, and Growth Analysis" report has been added to ...

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian Bot, a renowned biopharmaceutical founder and...

Advances diabetes and obesity programs with icovamenib demonstrating durable 52-Week Phase II data and with BMF-650, Biomea’s next-generation, oral small molecule glucagon-like peptide-1 (“GLP-1”)...